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Optimal Control of Tuberculosis: A Review∗
Cristiana J. Silva and Delfim F. M. Torres
Abstract We review the optimal control of systems modeling the dynamics of tu-
berculosis. Time dependent control functions are introduced in the mathematical
models, representing strategies for the improvement of the treatment and cure of ac-
tive infectious and/or latent individuals. Optimal control theory allows then to find
the optimal way to implement the strategies, minimizing the number of infectious
and/or latent individuals and keeping the cost of implementation as low as possi-
ble. An optimal control problem is proposed and solved, illustrating the procedure.
Simulations show an effective reduction in the number of infectious individuals.
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1 Introduction
Mycobacterium tuberculosis is the cause of most occurrences of tuberculosis (TB)
and is usually acquired via airborne infection from someone who has active TB. It
typically affects the lungs (pulmonary TB) but can affect other sites as well (extra-
pulmonary TB). Only approximately 10% of people infected with M. tuberculosis
develop active TB disease. Therefore, approximately 90% of people infected remain
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latent. Latent infected TB people are asymptomatic and do not transmit TB, but may
progress to active TB through either endogenous reactivation or exogenous reinfec-
tion [52, 53]. Following the World Health Organization (WHO), between 1995 and
2011, 51 million people were successfully treated for TB in countries that adopted
the WHO strategy, saving 20 million lives [60]. However, the global burden of TB
remains enormous. In 2011, there were an estimated 8.7 million new cases of TB
(13% co-infected with HIV) and 1.4 million people died from TB [60]. The increase
of new cases has been attributed to the spread of HIV, the collapse of public health
programs, the emergence of drug-resistant strains of M. tuberculosis [19, 37, 38]
and exogenous re-infection, where a latently-infected individual acquires a new in-
fection from another infectious (see [6, 12, 17] and references cited therein). In the
absence of an effective vaccine, current control programs for TB have focused on
chemotherapy. Lack of compliance with drug treatments not only may lead to a
relapse but to the development of antibiotic resistant TB, called multidrug-resistant
TB (MDR-TB), which is one of the most serious public health problems facing soci-
ety today [27]. The progress in responding to multidrug-resistant TB remains slow.
There are critical funding gaps for TB care and control, which is critical to sustain
recent gains, make further progress and support research and development of new
drugs and vaccines [60].
Mathematical models are an important tool in analyzing the spread and control
of infectious diseases [26]. Understanding the transmission characteristics of the
infectious diseases in communities, regions and countries, can lead to better ap-
proaches to decrease the transmission of these diseases [25, 42, 49]. There are many
mathematical dynamic models for TB, see, e.g., [4, 8, 13, 14, 21, 48, 58]. Most
models consider that there are two different ways to progress to active disease af-
ter infection: “fast progressors” and “slow progressors”. It is also considered that
only 5 to 10% of the infected individuals are fast progressors. The remaining are
able to contain the infection (latent infected individuals) and have a much lower
probability to develop active disease by endogenous reactivation. More recent mod-
els also consider the possibility of latent and treated individuals being reinfected,
since it was already recognized that infection and/or disease do not confer full pro-
tection [57]. Models show that reinfection can be an important component of TB
transmission and can have impact on the efficacy of interventions [13, 21, 45, 58].
Here we focus on TB models that consider: development of drug resistant TB [7];
exogenous reinfection [5, 6, 16, 17, 22, 35]; fast and slow progression to infection
[5, 6, 16, 22]; post-exposure interventions [22]; immigration of infectious individ-
uals [35]; and time-dependent parameters [59]. These models can be particularly
useful in comparing the effects of various prevention, therapy and control programs
[25, 32]. Since a variety of these programs are available, it is a natural objective to
design optimal programs in terms of some pre-assumed criterion. This calls for the
application of optimal control tools [33].
Optimal control has a long history of being applied to problems in biomedicine,
particularly, to models for cancer chemotherapy [15, 29, 30, 31, 32, 34, 54, 55, 56].
But until recently, little attention has been given to models in epidemiology [3, 20,
32, 40, 41, 43, 46]. In this paper we review the application of optimal control to
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TB mathematical models. The first paper appeared in 2002 [27], and considers a
mathematical model for TB based on [7] with two classes of infected and latent in-
dividuals (infected with typical and resistant strain TB) where the aim is to reduce
the number of infected and latent individuals with resistant TB. Two control strate-
gies are proposed to achieve the objective: a case finding control measure, referring
to the identification of individuals latently infected with typical TB and who are at
high risk of developing the disease and who may benefit from prevention therapy
(reducing the number of latent individuals that develop the disease) [27, 39]; and
a case holding control, representing the effort that prevents the failure of the treat-
ment in the typical TB infectious individuals and referring to activities and tech-
niques used to ensure regularity of drug intake for a duration adequate to achieve
a cure (reducing the incidence of acquired drug-resistant TB) [11, 27]. In [24] the
authors consider the problem of minimizing the number of infectious individuals
with a control intervention representing the effort on the prevention of the exoge-
nous reinfection. The authors of [35] propose the implementation of a case finding
control, representing the fraction of active infectious individuals that are identified
and will be isolated in a facility, for an effective treatment and prevention of contact
with susceptible and latent individuals, and a control measure based on the medical
testing/screening of new immigrants before they are allowed into the population.
In [59] three control interventions are studied with the aim of reducing the num-
ber of latent and active infectious individuals: distancing control, representing the
effort of reducing susceptible individuals that become infected, such as, isolation
of infectious individuals or educational campaigns; case finding control applied to
latent individuals; and case holding control for infectious individuals. In [5, 6] case
finding and case holding control measures are proposed for the minimization of the
number of active infected individuals. In [16] the authors propose optimal control
strategies for reducing the number of individuals in the class of the lost to follow
up individuals. In [47, 50], optimal strategies for the minimization of the number of
active TB infectious and persistent latent individuals are proposed.
The study of optimal control strategies produce valuable theoretical results,
which can be used to suggest or design epidemic control programs. Depending on a
chosen goal (or goals), various objective criteria may be adopted [5]. Although the
implementation of the control policies, suggested by the mathematical analysis, can
be difficult, they can be a support for the public health authorities and simulation of
optimal control problems applied to mathematical models may become a powerful
tool in their hands (see [5] and references cited therein).
The manuscript is organized as follows. In Section 2 mathematical models for
TB dynamics are reviewed. They form, after introduction of the control functions,
the control system of the optimal control problems on TB epidemics under con-
sideration. The models with controls are presented in Section 3. A general optimal
control problem is formulated in Section 4, where we explain how to obtain the an-
alytic expression for the optimal controls, using the Pontryagin minimum principle
[36]. In Section 5 we recall the numerical methods used to compute the optimal con-
trols and associated dynamics. The main conclusions, derived from the numerical
simulations, are resumed. Finally, in Section 6, an example is given, illustrating the
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effectiveness of the implementation of the control strategies on a TB control disease.
We end with Section 7 of conclusions and future research.
2 Uncontrolled TB Models
Mathematical models have become important tools in analyzing the spread and con-
trol of infectious diseases [25]. In this section we present different mathematical TB
models which are, after some modifications, the control system of optimal control
problems on TB epidemics (see Section 3).
In an infectious disease model, the total population is divided into epidemiologi-
cal subclasses. Some of the standard classes are: susceptible individuals (S), latently
infected individuals (infected but not infectious) (E), infectious (I), and the recov-
ered and cured individuals (R). Eight possible compartmental models, described by
their flow patterns, are: SI, SIS, SEI, SEIS, SIR, SIRS, SEIR and SEIRS. For exam-
ple, in a SEIRS model, susceptible become exposed in the latent period, then infec-
tious, then recovered with temporary immunity and then susceptible again when the
immunity wears off [25]. Here, we choose to denote the class of latently infected
individuals by L and the class of recovered and cured individuals by T .
In [7] the authors present a SEIRS model for TB. The latently infected and infec-
tious individuals with typical TB are denoted by L1 and I1, respectively. The model
is given by

˙S(t) = Λ −β cS(t) I1(t)N(t) − µS(t),
˙L1(t) = β cS(t) I1(t)N(t) − (µ + k1 + r1)L1(t)+σβ cT(t) I1(t)N(t) ,
˙I1(t) = k1L1(t)− (µ + r2 + d1)I1(t),
˙T (t) = r1L1(t)+ r2I1(t)−σβ cT(t) I1(t)N(t) − µT (t),
(1)
where N denotes the total population, N(t) = S(t)+ L1(t)+ I1(t)+ T (t), Λ is the
recruitment rate, β and σβ are the probabilities that susceptible and treated indi-
viduals become infected by one infectious individual I1 per contact per unit of time,
respectively, c is the per-capita contact rate, µ is the per-capita natural death rate, k1
is the rate at which an individual leaves the latent class L1 by becoming infectious,
d1 is the per-capita TB induced death rate, and r1 and r2 are per-capita treatment
rates for latent and infectious individuals, respectively. It is assumed that an individ-
ual can be infected only through contacts with infectious individuals.
In the same paper [7], a two-strain model is presented which considers resistant
TB strain. Two subclasses of the total population are added: L2 (latent) and I2 (in-
fectious), representing the developmental stages of resistant strains. It is assumed
that I2 individuals can infect S, L1 and T individuals. The model is given by the
following system:
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
˙S(t) = Λ −β cS(t) I1(t)N(t) − µS(t)−β ∗cS(t) I2(t)N(t) ,
˙L1(t) = β cS(t) I1(t)N(t) − (µ + k1 + r1)L1(t)+σβ cT(t) I1(t)N(t) + pr2I1(t)
−β ∗cL1(t) I2(t)N(t) ,
˙I1(t) = k1L1(t)− (µ + r2 + d1)I1(t),
˙L2(t) = qr2I1(t)− (µ + k2)L2(t)+β ∗c(S(t)+L1(t)+T(t)) I2(t)N(t) ,
˙I2(t) = k2L2(t)− (µ + d2)I2(t),
˙T (t) = r1L1(t)+ (1− p− q)r2I1(t)−σβ cT(t) I1(t)N(t) − µT (t)−β ∗cT (t) I2(t)N ,
(2)
with N(t) = S(t)+ L1(t)+ I1(t)+ L2(t)+ I2(t)+ T(t) and where β ∗ is the proba-
bility that treated individuals become infected by one resistant-TB infectious indi-
vidual I2 per contact per unit of time, d2 and k2 have similar meanings as d1 and k1
for resistant-TB, and p+ q is the proportion of those treated infectious individuals
who did not complete their treatment. The proportion p modifies the rate that de-
parts from the latent class, and qr2I1(t) gives the rate at which individuals develop
resistant-TB due to an incomplete treatment of active TB. Therefore, p ≥ 0, q ≥ 0
and p+ q≤ 1.
The results of [17] suggest that exogenous reinfection has a drastic effect on the
qualitative dynamics of TB. If we introduce into model (1) the term ρβ cL1I1/N,
which represents exogenous reinfection, we obtain the exogenous reinfection tuber-
culosis model developed in [17]. The parameter ρ represents the level of reinfection.
A value of ρ ∈ (0,1) implies that reinfection is less likely than a new infection. In
fact, a value of ρ ∈ (0,1) implies that a primary infection provides some degree of
cross immunity to exogenous reinfections. A value of ρ ∈ (1,∞) implies that TB
infection increases the likelihood of active TB. The authors take the conservative
view that 0 < p < 1 (see (6) in Section 3 for the model with controls).
In [35] a mathematical model is presented, which takes into account immigration
of infectious individuals as well as isolation of the infectious individuals for treat-
ment. The model without controls is an extension of that of [17]: one subclass of
the total population, the class of isolated infectious individuals with typical TB, is
added. The corresponding controlled model is given in Section 3, by (7).
In [5, 6, 16] fast and slow progression to the infectious class are considered and
both models consider exogenous reinfection, chemoprophylaxis of latently infected
individuals and treatment of active infected individuals. In [6] a SEI model is pro-
posed, where the infective class is divided into two subclasses: diagnosed infectious
(those who have an active TB confirmed after an examination in a hospital) and
undiagnosed infectious (i.e., those who have an active TB but not confirmed by an
examination in a hospital), denoted by I1 and I2, respectively. The model in [6] is
given by the following system of ordinary differential equations:
6 C. J. Silva and D. F. M. Torres

˙S = Λ −β I1N S− µS ,
˙L1 = (1− g)β I1N S+ r2I1 + r3I2− (1− r1)σλ L1− [µ + k1(1− r1)]L1 ,
˙I1 = g f β I1N S+ h(1− r1)(k1 +σβ I1N )L1− (µ + d1 + r2)I1 ,
˙I2 = g(1− f )λ S+(1− h)(1− r1)(k+σλ )E − (µ + d3+ r3)J ,
(3)
where the fraction g of newly infected individuals are assumed to undergo a fast
progression directly to TB, while the remainder is latently infected and enter the la-
tent class L1. Among the newly infected individuals that undergo a fast progression
to TB, a fraction f of them is detected, and will enter the diagnosed infectious class
I1, while the remaining 1− f is undetected and will be transferred into the undiag-
nosed infectious class I2. In this model r2 is the rate of effective per capita therapy
of diagnosed infectious individuals I1. It is assumed that undiagnosed infectious in-
dividuals can naturally recover and will be transferred into the latent class L1 at a
constant rate r3 < r2. Here σ is the factor reducing the risk of infection as a result
of acquiring immunity for latently infected individuals L1. Among latently infected
individuals who become infectious, the fraction h of them is diagnosed and treated,
while the remaining 1− h is not diagnosed and enters the undiagnosed infectious
class I2. The parameter d3 is the per capita TB induced death rate for undiagnosed
infectious individuals. If we consider f = 1, h= 1, r3 = 0 and d3 = 0, then we obtain
the model proposed in [5].
In [22] the authors present a model for TB that considers exogenous reinfection
and post-exposure interventions. The class L3 denotes the fraction of early latent
individuals, that is, individuals that were recently infected (less than two years) and
are not yet infectious; while L4 denotes the class of persistent latent individuals who
where infected and remain latent. The other classes are S, I1 and T , with the same
meaning has in the previous models. The model of [22] is given by the following
system:

˙S(t) = µN− βN I1(t)S(t)− µS(t),
˙L3(t) = βN I1(t)(S(t)+σL4(t)+σRT (t))− (δ + τ1 + µ)L3(t),
˙I1(t) = k1δL3(t)+ωL4(t)+ωRT (t)− (τ0 + µ)I1(t),
˙L4(t) = (1− k1)δL3(t)−σ βN I1(t)L4(t)− (ω + τ2 + µ)L4(t),
˙T (t) = τ0I1(t)+ τ1L3(t)+ τ2L4(t)−σR βN I1(t)T (t)− (ωR + µ)T (t) .
(4)
Here σ has the same meaning has in the model (3) but applies to persistent latent
individuals, L4, and σR represents the same parameter factor but for treated patients;
δ denotes the rate at which individuals leave the L3 compartment; ω is the rate of
endogenous reactivation for persistent latent infections (untreated latent infections);
ωR is the rate of endogenous reactivation for treated individuals (for those who have
undergone a therapeutic intervention); τ0 is the rate of recovery under treatment of
active TB (assuming an average duration of infectiousness of six months); τ1 and
τ2 apply to latent individuals L3 and L4, respectively, and are the rates at which
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chemotherapy or a post-exposure vacine is applied. In this model it is assumed that
the total population is constant, i.e., the rate of birth and death, µ , are equal and
there are no disease-related deaths.
3 Controlled TB Models
The model (2) is the basis of the work developed in [27], where two control func-
tions, u1 and u2, are introduced, representing control strategies for the two-strain TB
model. The control system is given by

˙S(t) = Λ −β cS(t) I1(t)N(t) − µS(t)−β ∗cS(t) I2(t)N(t) ,
˙L1(t) = β cS(t) I1(t)N(t) − (µ + k1 + u1(t)r1)L1(t)+σβ cT(t) I1(t)N(t)
+(1− u2(t))pr2I1(t)−β ∗cL1(t) I2(t)N(t) ,
˙I1(t) = k1L1(t)− (µ + r2 + d1)I1(t),
˙L2(t) = (1− u2(t))qr2I1(t)− (µ + k2)L2(t)+β ∗c(S(t)+L1(t)+T (t)) I2(t)N(t) ,
˙I2(t) = k2L2(t)− (µ + d2)I2(t),
˙T (t) = u1(t)r1L1(t)+ (1− ((1− u2(t)))(p+ q))r2I1(t)−σβ cT(t) I1(t)N(t)
−µT (t)−β ∗cT (t) I2(t)N(t) .
(5)
The control u1 represents the fraction of typical TB latent individuals, L1, that is
identified and put under treatment (to reduce the number of individuals that may be
infectious). The coefficient 1− u2(t) represents the effort that prevents the failure
of the treatment in the typical TB infectious individuals (to reduce the number of
individuals developing resistant TB). When the control u2 is near 1, there is low
treatment failure and high implementation costs.
In [24] the authors consider the exogenous reinfection TB model presented in
[17] and introduce a control which simulates the effect of exogenous reinfection,
that is, they consider a fixed value for ρ , ρ = 0.4, and multiply the term ρβ cL1I1/N
by 1−u. The coefficient 1−u represents the effort that prevents the exogenous rein-
fection in order to reduce the contact between the infectious and exposed individu-
als, thus decreasing the number of infectious individuals. The exogenous reinfection
TB model with control, proposed in [24], is given by
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
˙S(t) = Λ −β cS(t) I1(t)N(t) − µS(t),
˙L1(t) = β cS(t) I1(t)N(t) − pβ c(1− u(t))L1(t) I1(t)N(t) − (µ + k1)L1(t)+σβ cT(t) I1(t)N(t) ,
˙I1(t) = pβ c(1− u(t))L1(t) I1(t)N(t) + k1L1(t)− (µ + r2 + d1)I1(t),
˙T (t) = r2I1(t)−σβ cT(t) I1(t)N(t) − µT(t),
(6)
with N(t) = S(t)+L1(t)+ I1(t)+T (t).
In [35] the model takes into account immigration of infectious individuals as well
as isolation of the infectious for treatment. Two control functions are considered: u1
and u2. The control u1 accounts for medical testing/screening of new immigrants,
before they are allowed into the population, while the coefficient 1−u1 is the effort
that sustains such a testing policy. The control u2 is a case finding control that rep-
resents the fraction of active individuals that are identified and will be isolated in
a special facility, like a hospital, for effective treatment and prevention of contacts
with susceptible and latent individuals. Hence, the term 1+ u2 represents the effort
that sustains the isolation policy. The model with controls is given by

˙S = Λ∗+(1− (1− u1(t))(p∗+ q∗))A−β cS I1+lJN − µS,
˙L1 = (1− u1(t))p∗A+(1−m)β cS I1+lJN − pβ cL1 I1+lJN +σβ cT I1+σJN
−(k1 + µ)L1,
˙I1 = (1− u1(t))q∗A+mβ cS I1+lJN + pβ cL1 I1+lJN + k1L1 − (µ + d3 + r2)I1
−(1+ u2(t))ξ I1,
˙J = (1+ u2(t))ξ I1− (r3 + µ + d4)J,
˙T = r2I1 + r3J−σβ cT I1+σJN − µT.
(7)
The constant A represents the number of new members arriving into the population,
per unit of time; p∗ is the fraction of A arriving infected with latent TB; and q∗ is the
fraction of A arriving infected with active TB, so that 0 ≤ p∗+q∗ ≤ 1. It is assumed
that 1− (p∗− q∗)A individuals are free from the disease. The parameter Λ∗ is the
recruitment rate. Here the population is replenished from births and immigration;
d3 and d4 are the typical TB-induced mortality rates for active TB individuals, that
were not isolated from the population, and for isolated TB cases, respectively; r3 is
the treatment rate for isolated infectious individuals. The parameter l is the isolation
level and lies in the range 0 ≤ l ≤ 1, where l = 0 indicates absolute isolation for
active infectious TB cases and l = 1 indicates no effective isolation. The parameter
0≤σ∗≤ 1 determines the level of contact that treated individuals have with isolated
individuals. The authors assume that σ∗ < l and that the treated individuals have a
reduced contact with the isolated infectious group, as some of the treated individuals
are from the J class. By m, 0 < m < 1, it is denoted the fraction of persons with new
infections who develop to TB fast, per unit of time, while ξ is the rate of isolation.
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The parameters µ , β , c, σβ , k1, p, σ and r2, have the same meaning as in the
previous models (see Table 1).
Symbol Description
Λ Recruitment rate
µ Per-capita natural death rate
b Effective birth rate
d1 Per-capita typical TB induced death rate
d2 Per-capita resistant TB induced death rate
β Rate at which susceptible individuals become infected by an infectious individual
with typical TB
β ∗ Rate at which susceptible individuals become infected by one resistant-TB
infectious individual
σβ Rate at which treated individuals become infected by an infectious individual
with typical TB
c Per-capita contact rate
k1 Rate of progression to active TB
k2 Rate of progression to active resistant TB
r Per-capita treatment rate
r1 Treatment rate of individuals with latent typical TB
r2 Treatment rate of individuals with infectious typical TB
r3 Treatment rate of undiagnosed infectious individuals
1− s Treatment success rate
p Level of exogenous reinfection
u+ v Proportion of treated infectious individuals who did not complete their treatment
g Fraction of newly infected individuals that undergo a fast progression
to the infectious class
f Fraction of newly infected individuals that undergo a fast progression to TB
h Fraction of infectious individuals that are diagnosed and treated
σ Factor reducing the risk of infection as a result of acquiring immunity
for latently infected individuals
σR Factor reducing the risk of infection as a result of acquiring immunity
for treated individuals
δ Rate at which individuals leave L3 compartment
α Non-progress rate from L1 to I
ω Rate of endogenous reactivation for persistent latent infections
ωR Rate of endogenous reactivation for treated infections
τ0 Rate of recovery under treatment of active TB
τ1 Rate of recovery under treatment of latent individuals L3
τ2 Rate of recovery under treatment of latent individuals L4
N Total population
Table 1: Parameters that are used in the mathematical models for TB transmission
(with and without controls).
In [59] the authors modified a model from [2] in order to study the transmis-
sion dynamics for TB in South Korea in the forty years period from 1970 to 2009.
The total population, N, is divided into susceptible individuals (S), hight-risk la-
tent (L1) that are recently infected but not infectious, active-TB infectious (I) and
permanently latent (L5) with low risk. The main difference from the other TB mod-
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els is the incorporation of time-dependent parameters. The birth and mortality rates
are assumed as the time-dependent functions b(t) and µ(t), respectively. The time-
dependent function k(t) is the per-capita rate of progression to active-TB from the
recently latent class L1. Individuals who do not progress from the class L1 to the
class I and those who are treated in the class L1, are moved to the class L5 at the per-
capita rate α and r(t), respectively. The time-dependent function s(t) is the propor-
tion of treated infectious individuals who did not complete their treatment; 1− s(t)
is the treatment success rate for active tuberculosis. As previously, the parameter β
is the number of new infections with active-TB per unit of time. The authors pro-
pose optimal control treatment strategies of TB in South Korea, for the period from
2010 to 2030, for various possible scenarios. Since it is not feasible to have the mor-
tality data or the total population data for the future, the authors used the averaged
constant values from the year 2001 to 2009 instead of using b(t), µ(t), s(t) and r(t).
The estimated time-dependent k(t) from the year 1970 to 2009 is, however, used to
find the optimal treatment strategy for the future. Three time-dependent controls are
introduced into the TB system. The control u1(t) is the distancing control and the
coefficient 1− u1(t) represents the effort of reducing susceptible individuals that
become infected by infectious individuals, such as isolation of infectious people
or educational programs/campaigns for healthy control. The case finding control,
u2(t), represents the effort of decreasing the number of individuals that may be in-
fectious, such as identification through screening of latent individuals who are in
high risk of developing TB and who may benefit from prevention intervention. The
case holding control, 1− u3(t), represents the effort of reducing the reinfection in-
dividuals, such as taking care of patients until they complete their treatment. The
control system is given by

˙S(t) = bN(t)− µS(t)− (1− u1(t))β S(t)N(t) I(t) ,
˙L1(t) = (1− u1(t))β S(t)N(t) I(t)− (k(t)+ u2(t)α + µ)L1(t)+ (1− u3(t))srI(t),
˙I(t) = k(t)L1(t)− (r+ µ)I(t) ,
˙L5(t) = (1− (1− u3(t))s)rI(t)+ u2(t)αL1(t)− µI(t) ,
where N(t) = S(t)+L1(t)+ I(t)+L5(t).
In [5] the author formulates an optimal control problem where one control, u,
is introduced in the TB model. The control represents the effort on the chemopro-
phylaxis parameter (r1) of latently infected individuals to reduce the number of in-
dividuals that may develop active TB. The model with control is given by (3) with
1− u1r1 instead of 1− r1 and considering f = h = 1 and d2 = r3 = 0. In [6], addi-
tionally to the control u1, a second control u2 is included in the model (3), which
represents the effort on detection (h) of infectious, to increase the treatment rate of
infectious and, consequently, to reduce the number of infectious and the source of
infection. The model with controls is given by (3) with 1− u1r1 instead of 1− r1
and u2h instead of h.
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In [16] the authors propose a model adapted to Africa, in particular to Cameroon.
A new class of individuals, called the lost to follow up individuals, is introduced.
The individuals in this class are active infectious individuals who didn’t take the
treatment until the end, due to a brief relief of a long time treatment. Some of the lost
to follow up individuals can transmit the disease without presenting any symptom.
The authors present control measures for the reduction of the number of individuals
that progress to the class of the lost to follow up individuals, L.
In [47, 50] two control functions, u1 and u2, and two real positive constants, ε1
and ε2, were introduced in the model (4). The control u1 represents the effort in
preventing the failure of treatment in active TB infectious individuals I1 (case hold-
ing), and the control u2 governs the fraction of persistent latent individuals L4 that is
put under treatment (case finding). The parameters εi ∈ (0,1), i = 1,2, measure the
effectiveness of the controls ui, i = 1,2, respectively, i.e., these parameters measure
the efficacy of treatment interventions for active and persistent latent TB individuals,
respectively. In [47] the model is applied to Angola.
In [27, 47, 50] it is assumed that the total population N is constant, that is, the
recruitment rate is equal to µN, Λ = µN, and the TB induced death rates are equal
to zero. In [5, 6, 16, 24, 35, 59] the total population is not considered to be constant.
4 Optimal Control Problems
The control strategies for the reduction of infectious and/or latent individuals im-
ply a cost of implementation. This implementation cost depends on many factors,
for example, costs for activities to facilitate case holding. Those activities can be
challenging because of the fact that chemotherapy must be maintained for several
months to ensure a lasting cure, but patients usually recover their sense of well-
being after only a few weeks of treatment and may often stop taking medications
[27, 39]. For case finding, the control policies consider actions for the prevention of
disease development with preventive therapy of latently infected individuals, which
can be done in different ways, for example, identifying TB cases where the first
initiative patient/provider contact is taken by health providers (active case finding)
or by the patient (passive case finding), and screening activities among population
groups at high risk of TB (for example, immigrants from high prevalence countries)
[27, 35]. The implementation cost is taken into account in the formulation of an
optimal control problem and is mathematically traduced by a functional.
Let L and I denote the latent infected and infectious individuals, respectively,
without any specific characteristic, and u = (u1, . . . ,un), with n ∈ {1,2,3} for the
models described in Section 3, be the bounded Lebesgue measurable control func-
tion. Different cost functionals have been considered on the previously cited works
on optimal control applied to TB models:
C1(u) =
∫ t f
0
[
A1I(t)+A2L(t)+
n
∑
i=1
Bi
2 u
2
i (t)
]
dt ,
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C2(u) =
∫ t f
0
[
A1I(t)+
n
∑
i=1
Bi
2
u2i (t)
]
dt ,
and
C3(u) =
∫ t f
0
[
A2L(t)+
n
∑
i=1
Bi
2
u2i (t)
]
dt .
It is assumed that the cost of the treatments are nonlinear and take a quadratic form.
The coefficients, A j, j ∈ {1,2}, and Bi, i ∈ {1,2,3}, are balancing cost factors due
to the size and importance of the three parts of the objective functional.
For the cost functional C2 and C3, the aim is to minimize the infectious and latent
individuals, respectively, while keeping the cost low. For the cost functional C1,
both infectious and latent individuals are wished to be minimized, keeping the cost
of control interventions low.
A cost functional of type C1 is adopted by [27, 47, 50, 59], C2 is chosen in
[5, 6, 24, 35] and C3 is the objective functional in [16].
Let (S ) denote a mathematical model for TB with controls (see Section 3) given
by a finite number, m, of differential equations. Assume that the control system (S )
is given by ˙X = f (X ,u), where f is a Lipschitz continuous function with respect
to the state variable X , X ∈ Rm, on the time interval [0, t f ] and X(0) = X0 be the
initial condition. Moreover, let g(X ,u) denote the integrand of the cost functional
C under consideration and assume that g is convex with respect to the control u.
The optimal control problem consists in finding a control u∗ such that the associated
state trajectory X∗ is solution of the control system (S ), in the time interval [0, t f ]
with initial conditions X∗(0), and minimizes the cost functional C,
C(u∗) = min
Ω
C(u) , (8)
where Ω is the set of admissible controls (bounded and Lebesgue integrable func-
tions) given by
Ω =
{
u ∈ L1(0, t f ) |0 ≤ ui ≤ 1 , i = 1, . . . ,n
}
.
According to the Pontryagin minimum principle [36], if u∗(·) ∈ Ω is optimal
for the optimization problem (8) subject to the control system (S ) with fixed ini-
tial conditions X0 and fixed final time t f , then there exists a nontrivial absolutely
continuous mapping λ : [0, t f ]→Rm, called the adjoint vector, such that
˙X =
∂H
∂λ (9)
and
˙λ =−∂H∂X , (10)
where the function H defined by
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H = H(X(t),λ (t),u(t)) = g(X(t),u(t))+ 〈λ (t), f (X(t),u(t)〉
is called the Hamiltonian, and the minimization condition
H(X∗(t),λ ∗(t),u∗(t)) = min
0≤u≤1
H(X∗(t),λ ∗(t),u) (11)
holds almost everywhere on [0, t f ]. Moreover, the transversality conditions
λi(t f ) = 0, i = 1, . . . ,m , (12)
hold. This approach was considered in [6, 16, 24, 27, 35, 47, 59] for obtaining an
analytic expression of the optimal control u∗. In [5] the analytical expression of
the optimal control u∗ is derived, using an algebraic approach, by solving a Riccati
equation.
5 Numerical Methods and Simulations
In [27] the optimal treatment strategy is obtained by solving the optimality system,
consisting of 12 ODEs from (5) and adjoint equations (10). An iterative method is
used for solving the optimality system. The authors start to solve the state equa-
tions with a guess for the controls over the simulated time using a forward fourth
order Runge–Kutta scheme. Because of the transversality conditions (12), the ad-
joint equation are solved by a backward fourth order Runge–Kutta scheme using
the current iteration solution of the state equations. Then, the controls are updated
by using a convex combination of the previous controls and the value from the char-
acterizations derived by (11). This process is repeated and iteration is stopped if
the values of unknowns at the previous iteration are close enough to the ones at
the present iteration. The same numerical procedure is applied in [16, 35, 59]. In
[47, 50] the authors use also the software IPOPT [61], the Matlab Optimal Con-
trol Software PROPT [63] and the algebraic modeling language AMPL [62]. See,
for example, [1] for details on numerical simulations of optimal control applied to
life sciences using Matlab. In [24] the authors apply a semi-implicit finite diference
method developed by [23] and presented in [28]. For a gentle overview see [44].
In [27] different optimal control strategies are presented, which depend on the
population size, cost of implementing treatment controls and the control parame-
ters. The authors conclude that programs that follow the proposed control strategies
can effectively reduce the number of latent and infectious resistant-strain TB cases.
In [24] the numerical results show the effectiveness to introduce the control that
prevents the exogenous reinfection, which reactivates the bacterium tuberculosis at
the latent individuals. Analogously, in [5, 6] the results emphasize the importance
of controlling exogenous reinfection using chemoprophylaxis and detection meth-
ods in reducing the number of actively infected individuals with tuberculosis. The
numerical simulations in [35] show that the proposed control interventions can ef-
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fectively reduce the number of latent and infectious TB cases. More precisely, the
optimal control results show that a cost effective combination of screening/medical
testing of immigrants, as well as isolation of infectious persons for treatment, may
depend on cost of implementation of the controls and the parameters of the model,
specially, the rate of isolation ξ , isolation level l, fraction of immigrants with latent
TB p, and fraction of immigrants with active TB q.
6 Example: Optimal Control for the TB SEIRS Model
In this section we introduce a case finding control function u to the SEIRS mathe-
matical model for TB (1) from [7]. The coefficient 1−u(t) represents the effort that
sustains the success of the treatment of latent individuals L1. We assume that the
total population N is constant, that is, d1 = 0. This assumption is appropriate when
the time period is short or when the natural deaths or the immigration balances the
emigration (see [25]).
The controlled model is given by (see Table 1 for the meaning of the parameters)

˙S(t) = Λ − βN cS(t)I1(t)− µS(t),
˙L1(t) = βN cS(t)I1(t)− (µ + r1)L1(t)− (1− u(t))k1L1(t)+σ
β
N cT (t)I1(t),
˙I1(t) = (1− u(t))k1L1(t)− (µ + r2 + d1)I1(t),
˙T (t) = r1L1(t)+ r2I1(t)−σ βN cT (t)I1(t)− µT(t).
(13)
Our aim is to minimize the number of infectious individuals I1, while keeping the
cost of control strategies implementation low, that is, (we choose a cost functional
of type C2 of Section 4)
C(u) =
∫ t f
0
[
AI1(t)+
B
2 u
2(t)
]
dt . (14)
In this example we propose to solve the optimal control problem that consists in
finding a control u∗ such that the associated state trajectory (S∗,L∗1, I∗1 ,T ∗) is so-
lution of the control system (13) in the time interval [0, t f ] with initial conditions
(S(0),L1(0), I1(0),T (0)) and minimize the cost functional C,
C(u∗) = min
Ω
C(u) , (15)
where Ω is the set of admissible controls given by
Ω = {u ∈ L1(0, t f ) |0 ≤ u ≤ 1} .
Theorem 1. The optimal control problem (13), (15) with fixed initial conditions
S(0), I1(0), L1(0) and T (0) and fixed final time t f , admits an unique solution
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(S∗(·), I∗1 (·),L∗1(·),T ∗(·)) associated to an optimal control u∗(·) on [0, t f ]. Moreover,
there exists adjoint functions λ ∗1 (·), λ ∗2 (·), λ ∗3 (·) and λ ∗4 (·) such that

˙λ ∗1 (t) = λ ∗1 (t)
( β
N cI
∗
1(t)+ µ
)
−λ ∗2 (t)
β
N cI
∗
1 (t),
˙λ ∗2 (t) = λ ∗2 (t)((µ + r1)+ (1− u∗(t))k1)−λ ∗3 (t)(1− u∗(t))k1−λ ∗4 (t)r1,
˙λ ∗3 (t) =−A+λ ∗1 (t)
β
N cS
∗(t)−λ ∗2 (t)
( β
N cS
∗(t)+σ βN cT ∗(t)
)
+λ ∗3 (t)(µ + r2 + d1)−λ ∗4 (t)
(
r2−σ
β
N cT ∗ (t))
)
,
˙λ ∗4 (t) =−λ ∗2 (t)σ
β
N cI
∗
1 (t)+λ ∗4 (t)
(
σ βN cI∗1(t)− µ
)
,
(16)
with transversality conditions
λ ∗i (t f ) = 0, i = 1, . . . ,4 .
Furthermore,
u∗(t) = min
{
max
{
0, k1
B
L∗1(t)(λ ∗3 (t)−λ ∗2 (t))
}
,1
}
. (17)
Proof. Existence of an optimal solution (S∗,L∗1, I∗1 ,T ∗), associated to an optimal
control u∗, comes from the convexity of the integrand of the cost functional (14) with
respect to the control u and the Lipschitz property of the state system with respect
to state variables (S,L1, I1,T ) (see, e.g., [10, 18]). System (16) is derived from the
Pontryagin minimum principle (see (10), [36]) and the optimal control (17) comes
from the minimization condition (11). The optimal control given by (17) is unique
along all time interval due to the boundedness of the state and adjoint functions,
the Lipschitz property of systems (13) and (16) and the fact that the problem is
autonomous.
We end by presenting some numerical simulations with the following parame-
ter values: µ = 0.0143, c = 1, β = 13, σ = 1, r1 = 2, and r2 = 1 (see [7]). The
initial conditions are: S(0) = (76/120)N, L1(0) = (38/120)N, I1(0) = (5/120)N,
and T (0) = (1/120)N (see [27]). We start showing that the implementation of the
control has a positive impact on the reduction of infectious individuals. In Figure 1
we observe that the fraction of infectious individuals decreases significatively when
control strategies are implemented. If our aim is to reduce the number of infectious
individuals giving special attention to keep the cost of implementation of the con-
trol measures low, then the weight constant B should take bigger values than A.
Take, without loss of generality, A = 1 and B ≥ 50. In this case, we observe that the
fraction of infectious individuals I1/N and the optimal control u depend on the rate
of progression to active TB (see Figure 2) and the size N of total population (see
Figure 3). The period of time that the optimal control attains its maximum value
increases with B (see Figure 4). However, contrary to what is desired, the fraction of
infectious individuals starts increasing after some specific period of time. This can
be avoided if the rate k of progression to active TB is low (see Figure 2), or if we
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Fig. 1: Fraction of infectious individuals, with and without control, and optimal
control (for k1 = 1, A = 1, B = 100 and N = 10000).
give more importance to the decrease of the number of infectious individuals than
to the cost of implementation of the control policies, that is, if we increase the value
of the weight constant A. In fact, for A ≥ B the fraction of infectious individuals
never increases in all treatment period, regardless the size of the population N or the
value of k (see Figure 5). On the other hand, the optimal control attains the maximal
value almost all the treatment period, which implies a higher cost implementation
of control measures (see Figure 6).
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Fig. 2: Fraction of infectious individuals and optimal control for k1 ∈
{0.25,0.5,0.75,1} (with B = 100, A = 1 and N = 10000).
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Fig. 3: Fraction of infectious individuals and optimal control for N ∈
{5000,10000,15000} (with B = 100, A = 1 and k1 = 1).
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Fig. 4: Fraction of infectious individuals and optimal control for B ∈
{50,100,250,500} (with A = 1, N = 10000 and k1 = 1).
7 Conclusion
A state of the art of uncontrolled and controlled mathematical models for tubercu-
losis (TB) has been presented. In particular, the paper reviews the works on optimal
control of various models for the disease transmission dynamics of TB. Several re-
sults related to the dynamics and optimal control of TB have been reviewed and
summarized. Two control strategies, “case finding” and “case holding”, are used to
demonstrate the optimal control analysis.
The topics covered do not provide an exhaustive survey but rather an illustrative
overview. For instance, a TB vaccine called BCG (Bacillus of Calmette and Gue´rin)
has been used especially for children for several decades, and in some papers a dy-
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Fig. 5: Fraction of infectious individuals for A = B = 100 (with k1 ∈
{0.25,0.5,0.75,1} and N ∈ {5000,10000,15000}).
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Fig. 6: Optimal control for A = B = 100 (with k1 ∈ {0.25,0.5,0.75,1} and N ∈
{5000,10000,15000}).
namical system with vaccination has been formulated and analyzed (see, e.g., [9]),
but the subject has not been covered here. The example provided (see Section 6)
is also very simple: only a single-strain TB dynamics with SEIRS model is pre-
sented. The reader interested in a model to study the optimal control of a two-strain
(drug-sensitive and drug-resistant) TB dynamics is referred to [27].
Current research includes the development of co-infection mathematical mod-
els for TB and human immunodeficiency virus (HIV) transmission dynamics [51].
The novelty of [51], with respect to available results in the literature, is considering
both TB and acquired immune deficiency syndrome (AIDS) treatment for individ-
uals with both infectious diseases. Results show that TB treatment for individuals
with only TB infection reduces the number of individuals that become co-infected
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with TB and HIV/AIDS, and reduces the diseases (TB and AIDS) induced deaths.
They also show that the treatment of individuals with only AIDS also reduces the
number of co-infected individuals. Further, TB-treatment for co-infected individu-
als in the active and latent stage of TB disease, implies a decrease of the number of
individuals that passes from HIV-positive to AIDS. Application of optimal control
to such combined TB-HIV/AIDS co-infection models poses a number of numerical
challenges and is under investigation. This will be addressed in a forthcoming paper.
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